NEWS: JANUARY 2006

-01/31/2006-

Press Release: Exeter Analytical (UK) Ltd., leaders in high performance CHN/O/S elemental analysis systems and consumables, have announced a merger with their sample analysis division - Warwick Analytical Services (WAS) to create a UK centre of excellence for elemental analysis.To read press release click here.

CombinatoRx Inc. and Fovea Pharmaceuticals SA form alliance for the treatment of ophthalmic diseases. To read article click here.

Sunesis Pharmaceuticals Inc. initiates Phase I clinical trials of CDK 2, 7 and 9 inhibitor SNS-032 for cancer. To read article click here.

Isis Pharmaceuticals licenses proprietary antibiotic program to Achaogen. To read article click here.

-01/30/2006-

Press Release: A high productivity Assay Assembly system has been announced that combines the plate storage and handling capabilities of the Velocity11 BioCel® Laboratory Automation platform with the nanolitre transfer technology of the Labcyte® Echo 550. To read press release click here.

Rigel Pharmaceuticals Inc. reaches milestone on Ligase research collaboration with Merck & Co. Inc. To read article click here.

-01/24/2006-

Press Release: Genevac, world leader in solvent removal technologies, recently marked the landmark of shipping its 2000th centrifugal evaporator. To read press release click here.

-01/20/2006-

Press Release: INTEGRA Biosciences, a specialist supplier of innovative laboratory products, has reported strong double-digit growth in international sales and value added in 2005. To read press release click here.

Press Release: Moritex, a world leader in skin analysis instrumentation since 1973, has announced that it will display its comprehensive cosmetic skin counselling instrument range at the Professional Beauty show due to take place at the ExCeL centre (London, UK) in March. To read press release click here.

Press Release: Porvair Sciences have announced a new 64-page catalogue providing a comprehensive specialist resource for all scientists involved with or using microplates and microplate technology. To read press release click here.

-01/17/2006-

Press Release: Micronic BV, specialists in traceable sample storage solutions, have introduced a novel lockable closing system to ensure the security of samples in tube rack. To read press release click here.

-01/16/2006-

Press Release: Genevac, world leader in solvent removal technologies, has announced the launch of a new second-generation version of its popular EZ-2 centrifugal evaporator. To read press release click here.

-01/13/2006-

Johnson & Johnson to acquire Guidant Corporation. To read article click here.

Pfizer Inc. to purchase Sanofi-aventis rights to Exubera®. To read article click here.

-01/12/2006-

Synthetech Inc. acquires peptide resin technology from Colorado Biotechnology Associates Inc. To read article click here.

FDA grants fast track designation to Favrille Inc.'s FavId® for the treatment of B-cell follicular non-Hodgkin's lymphoma. To read article click here.

-01/11/2006-

Pharmacopeia Drug Discovery Inc. deliveres to Organon two more lead compounds for metabolic and inflammatory diseases. To read article click here.

La Jolla Pharmaceutical Co. to begin multi-dose study of Riquent® in patients with lupus. To read article click here.

EntreMed Inc. acquires Miikana Therapeutics Inc. To read article click here.

Ablynx and Centocor Research and Development Inc. form research collaboration. To read article click here.

ActivBiotics Inc. and Metaphore Pharmaceuticals Inc. merge. To read article click here.

Glycotex Inc. halts IPO. To read article click here.

-01/10/2006-

Press Release: Available from Micronic BV is a new 16-page catalogue providing a background to the company's 25 year commitment to developing innovative traceable sample storage solutions and their range of products for pharmaceutical, clinical, veterinary science, food and agricultural applications. To read press release click here.

Chemicon International Inc. and MorphoSys AG form antibody research collaboration. To read article click here.

Novartis decides not to bid for Berna Biotech. To read article click here.

Elan Corporation and EntreMed Inc. ink license agreement for NanoCrystal Technology. To read article click here.

FDA approves Taclonex® for psoriasis treatment. To read article click here.

-01/09/2006-

Protein Design Labs Inc. changes its name PDL BioPharma Inc. To read article click here.

Savient Pharmaceuticals Inc. sells Delatestryl® to Indevus Pharmaceuticals Inc. To read article click here.

Gilead Sciences Inc. initiates Phase IIa clinical trials of JTK-303 (GS 9137) for the treatment of HIV. To read article click here.

Avalon Pharmaceuticals Inc. initiates Phase I clinical trials of AVN944 for cancer treatment. To read article click here.

-01/02/2006-

Press Release: ChemAxon announces free cheminformatics toolkit provision for non-commercial freely accessible web resources. To read press release click here.

FDA approves Chiron's West Nile test. To read article click here.